Takai K - Search Results

1

Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma.

Iritani S, Imai K, Takai K, Hanai T, Ideta T, Miyazaki T, Suetsugu A, Shiraki M, Shimizu M, Moriwaki H. Iritani S, et al. Among authors: takai k. J Gastroenterol. 2015 Mar;50(3):323-32. doi: 10.1007/s00535-014-0964-9. Epub 2014 May 10. J Gastroenterol. 2015. PMID: 24817668

2

Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. Updated analysis of the long-term follow-up data.

Takai K, Okuno M, Yasuda I, Matsushima-Nishiwaki R, Uematsu T, Tsurumi H, Shiratori Y, Muto Y, Moriwaki H. Takai K, et al. Intervirology. 2005;48(1):39-45. doi: 10.1159/000082093. Intervirology. 2005. PMID: 15785088 Clinical Trial.

3

Strategy and mechanism for the prevention of hepatocellular carcinoma: phosphorylated retinoid X receptor alpha is a critical target for hepatocellular carcinoma chemoprevention.

Shimizu M, Takai K, Moriwaki H. Shimizu M, et al. Among authors: takai k. Cancer Sci. 2009 Mar;100(3):369-74. doi: 10.1111/j.1349-7006.2008.01045.x. Epub 2008 Dec 4. Cancer Sci. 2009. PMID: 19068086 Free PMC article. Review.

4

Dietary supplementation with branched-chain amino acids suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db mice.

Iwasa J, Shimizu M, Shiraki M, Shirakami Y, Sakai H, Terakura Y, Takai K, Tsurumi H, Tanaka T, Moriwaki H. Iwasa J, et al. Among authors: takai k. Cancer Sci. 2010 Feb;101(2):460-7. doi: 10.1111/j.1349-7006.2009.01402.x. Epub 2009 Oct 15. Cancer Sci. 2010. PMID: 19906067 Free PMC article.

5

Insulin resistance raises the risk for recurrence of stage I hepatocellular carcinoma after curative radiofrequency ablation in hepatitis C virus-positive patients: A prospective, case series study.

Imai K, Takai K, Nishigaki Y, Shimizu S, Naiki T, Hayashi H, Uematsu T, Sugihara J, Tomita E, Shimizu M, Nagaki M, Moriwaki H. Imai K, et al. Among authors: takai k. Hepatol Res. 2010 Apr;40(4):376-82. doi: 10.1111/j.1872-034X.2009.00616.x. Epub 2010 Mar 4. Hepatol Res. 2010. PMID: 20236359

6

Long-term survival of a patient with splenic angiosarcoma after resection, high-dose chemotherapy, and autologous peripheral blood stem cell transplantation.

Hara T, Tsurumi H, Kasahara S, Ogawa K, Takada J, Imai K, Takai K, Kitagawa J, Kiyama S, Imai N, Oyama M, Takami T, Moriwaki H. Hara T, et al. Among authors: takai k. Intern Med. 2010;49(20):2253-7. doi: 10.2169/internalmedicine.49.3969. Epub 2010 Oct 15. Intern Med. 2010. PMID: 20962445 Free article.

7

Acyclic retinoid inhibits diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BLKS/J- +(db)/+Lepr(db) mice.

Shimizu M, Sakai H, Shirakami Y, Iwasa J, Yasuda Y, Kubota M, Takai K, Tsurumi H, Tanaka T, Moriwaki H. Shimizu M, et al. Among authors: takai k. Cancer Prev Res (Phila). 2011 Jan;4(1):128-36. doi: 10.1158/1940-6207.CAPR-10-0163. Epub 2010 Nov 11. Cancer Prev Res (Phila). 2011. PMID: 21071580

8

Possible role of visfatin in hepatoma progression and the effects of branched-chain amino acids on visfatin-induced proliferation in human hepatoma cells.

Ninomiya S, Shimizu M, Imai K, Takai K, Shiraki M, Hara T, Tsurumi H, Ishizaki S, Moriwaki H. Ninomiya S, et al. Among authors: takai k. Cancer Prev Res (Phila). 2011 Dec;4(12):2092-100. doi: 10.1158/1940-6207.CAPR-11-0340. Epub 2011 Sep 27. Cancer Prev Res (Phila). 2011. PMID: 21952585

9

Increased levels of serum leptin are a risk factor for the recurrence of stage I/II hepatocellular carcinoma after curative treatment.

Watanabe N, Takai K, Imai K, Shimizu M, Naiki T, Nagaki M, Moriwaki H. Watanabe N, et al. Among authors: takai k. J Clin Biochem Nutr. 2011 Nov;49(3):153-8. doi: 10.3164/jcbn.10-149. Epub 2011 Oct 29. J Clin Biochem Nutr. 2011. PMID: 22128212 Free PMC article.

10

Role of acyclic retinoid in the chemoprevention of hepatocellular carcinoma: basic aspects, clinical applications, and future prospects.

Shimizu M, Imai K, Takai K, Moriwaki H. Shimizu M, et al. Among authors: takai k. Curr Cancer Drug Targets. 2012 Nov 1;12(9):1119-28. Curr Cancer Drug Targets. 2012. PMID: 22873214 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,048 results

Search Page

Filters